Which ETFs own LKFT?
LAKEFRONT BIOTHERAPEUTICS — 5 ETFs hold it, worth $6.9M across 235.38K shares.
Holdings as of Aug 26, 2026 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | SBIO ALPS Medical Breakthroughs ETF | 0.93% | 76.12K | $2.2M | $242.4M | Biotech | -0.95% | |
| 2 | SCHC Schwab International Small-Cap Equity… | 0.06% | 107.66K | $3.2M | $5.79B | Developed Markets | -0.48% | |
| 3 | BIB ProShares Ultra Nasdaq Biotechnology | 0.01% | 513 | $14.8K | $107.7M | Biotech | -1.05% | |
| 4 | SPEU State Street SPDR Portfolio Europe ETF | 0.01% | 1.83K | $54.0K | $748.0M | Developed Markets | -0.45% | |
| 5 | SPDW State Street SPDR Portfolio Developed… | 0.00% | 49.25K | $1.5M | $42.23B | Developed Markets | -0.42% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.